Vardenafil (Levitra/Staxyn) Storage, Stability & Shelf Life

At a glance
- Recommended storage temperature / 20°C to 25°C (68°F to 77°F), with permitted excursions to 15°C to 30°C
- Shelf life (unopened, labeled conditions) / 24 months from date of manufacture
- Light sensitivity / vardenafil degrades under UV and visible light exposure
- Moisture sensitivity (Staxyn ODT) / must remain in sealed foil blister until immediately before dosing
- Regulatory classification / prescription-only (Schedule IV in some jurisdictions outside the U.S.)
- Available strengths (Levitra) / 2.5 mg, 5 mg, 10 mg, 20 mg film-coated tablets
- Available strength (Staxyn) / 10 mg orally disintegrating tablet
- Primary degradation pathway / oxidative and photolytic breakdown of the piperazine moiety
- Generic availability / yes, since 2018 (film-coated tablet only)
FDA-Labeled Storage Conditions for Vardenafil Tablets
Vardenafil film-coated tablets should be kept at controlled room temperature: 20°C to 25°C (68°F to 77°F). The FDA-approved prescribing information permits brief excursions between 15°C and 30°C (59°F to 86°F), consistent with USP Controlled Room Temperature guidelines [1]. That means a short car ride or a weekend in a bag at a hotel is acceptable, but leaving tablets in a glove compartment during summer is not.
Bayer's original Levitra labeling specifies storage in a "dry place" and protection from light [1]. Generic vardenafil tablets carry the same conditions. The film coating on standard tablets provides modest moisture protection, but it does not guard against sustained humidity above 75% relative humidity (RH). Pharmacies dispensing vardenafil in non-original containers (amber vials, pill organizers) should advise patients to keep the cap tightly closed and avoid bathroom medicine cabinets, where shower steam creates repeated humidity spikes.
For patients who travel frequently, a hard-sided pill case stored inside carry-on luggage (climate-controlled aircraft cabin) is preferable to checked baggage exposed to cargo hold temperature swings.
Staxyn ODT: A Formulation With Extra Storage Demands
Staxyn, the 10 mg orally disintegrating tablet (ODT), has stricter handling rules than the film-coated version. Each tablet sits inside an individually sealed aluminum foil blister, and the FDA labeling states it should not be removed until the moment of use [2]. The reason is simple: the ODT matrix is engineered to disintegrate on contact with saliva, so ambient moisture triggers premature breakdown.
Once a blister is peeled open, the tablet should be placed on the tongue immediately. Patients sometimes ask whether they can carry a loose Staxyn tablet in a pocket or wallet. The answer is no.
Staxyn also contains aspartame (a phenylalanine source), which itself is sensitive to heat-accelerated degradation. At temperatures above 30°C, aspartame hydrolyzes to diketopiperazine, producing a bitter off-taste that may signal thermal damage to the overall formulation [2]. The storage temperature range for Staxyn matches Levitra (20°C to 25°C, excursions to 15°C to 30°C), but the moisture constraint adds a second failure mode that film-coated tablets do not share.
Shelf Life and Expiration Dating
The FDA-approved shelf life for both Levitra and Staxyn is 24 months from date of manufacture, assuming storage within labeled conditions [1][2]. Generic vardenafil tablets approved through ANDA submissions must demonstrate equivalent stability profiles to the reference listed drug in ICH-compliant accelerated and long-term studies [3].
What does "24 months" mean in practice? If a pharmacy dispenses the medication 6 months after manufacture, the patient has roughly 18 months of labeled potency remaining. The expiration date printed on the packaging reflects the manufacturer's tested endpoint, not the date of dispensing. Patients who receive vardenafil in non-original packaging should note the pharmacy-assigned "discard after" or "beyond-use" date, which may be shorter (often 12 months from dispensing) per state pharmacy board rules.
A 2019 study published in the Journal of Pharmaceutical Sciences tested the chemical integrity of PDE5 inhibitors, including vardenafil, stored past their expiration dates. Tablets kept at controlled room temperature retained greater than 90% of labeled potency for up to 12 months beyond expiry [4]. That finding does not mean patients should use expired medication. It means the 24-month window includes a safety margin, but degradation accelerates unpredictably once storage conditions deviate from the label.
How Vardenafil Degrades: Photolytic and Oxidative Pathways
Vardenafil's chemical structure includes a piperazine ring and a sulfonamide group, both of which are targets for oxidative degradation [5]. Forced degradation studies (ICH Q1A stress testing) show three primary breakdown routes:
Photolysis. Exposure to UV light (254 nm and 365 nm) and visible light (fluorescent, direct sunlight) produces at least two identified photodegradants. A 2006 study in Journal of Pharmaceutical and Biomedical Analysis documented 8% to 12% loss of vardenafil content after 72 hours of ICH Q1B photostability testing at 1.2 million lux·hours [5]. Standard amber pharmacy vials reduce but do not eliminate photolytic risk during long-term storage.
Oxidation. Hydrogen peroxide stress (3% H₂O₂, 25°C, 24 hours) degrades vardenafil at the piperazine nitrogen, generating N-oxide impurities. This pathway is clinically relevant because high-humidity environments accelerate peroxide formation on tablet surfaces [5].
Acid/base hydrolysis. The sulfonamide bond cleaves under strongly acidic (pH <2) or strongly basic (pH >10) conditions, but this pathway is unlikely under normal storage. It becomes relevant for compounded liquid formulations of vardenafil, where pH must be controlled between 4.0 and 6.5.
The practical takeaway: keep vardenafil in a dark, dry, temperature-controlled location. A bedroom nightstand drawer meets all three criteria better than a bathroom cabinet or kitchen counter.
Temperature Excursions: What the ICH Data Show
Pharmaceutical stability testing follows ICH Q1A(R2) guidelines, which require manufacturers to test at three conditions: 25°C/60% RH (long-term), 30°C/65% RH (intermediate), and 40°C/75% RH (accelerated) [3]. Vardenafil's accelerated stability data at 40°C/75% RH for 6 months showed less than 5% degradation in film-coated tablets, confirming reasonable resilience to brief heat exposure [1].
But "brief" is the operative word. A tablet left in a parked car in Phoenix (interior temperatures reaching 70°C) faces conditions far beyond what 40°C/75% RH models. No manufacturer tests at those extremes because the labeled storage instructions exclude them entirely.
For patients living in hot climates or those without consistent air conditioning, a small insulated pouch (not a refrigerator) can buffer temperature swings. Refrigeration (2°C to 8°C) is not recommended for vardenafil; condensation on removal from cold storage introduces moisture that may damage the film coating or, in Staxyn's case, trigger premature disintegration.
Vardenafil vs. Other PDE5 Inhibitors: Comparative Stability
All four major PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) share a 24-month labeled shelf life under controlled room temperature [1][6][7]. Their degradation profiles differ because of structural variation.
Tadalafil is the most photostable of the group, owing to its methylenedioxyphenyl ring system, which absorbs UV energy without forming toxic degradants as readily [6]. Sildenafil is moderately photosensitive, similar to vardenafil. Avanafil is the most humidity-sensitive, with a hygroscopic free-base form that requires desiccant-containing packaging [7].
For vardenafil specifically, the Porst et al. (2003) trial that established efficacy in diabetic erectile dysfunction at 10 mg and 20 mg doses used tablets stored under ICH conditions, confirming that properly stored medication delivers the clinical benefit seen in trials: 72% of men on vardenafil 20 mg reported improved erections versus 13% on placebo [8].
The Endocrine Society's 2018 clinical practice guideline on testosterone therapy and PDE5 inhibitors notes that medication adherence, including proper storage, is an underappreciated factor in treatment failure [9]. A patient who reports that vardenafil "stopped working" should be asked where and how the medication is stored before dose escalation is considered.
Compounded Vardenafil: Unique Stability Considerations
Some compounding pharmacies prepare vardenafil in oral suspension or sublingual troche forms for patients who cannot swallow tablets. These formulations lack the film coating and controlled-release excipients of commercial products, so their stability profiles are shorter and more variable.
USP Chapter 795 (nonsterile compounding) assigns a default beyond-use date of 180 days for aqueous oral solutions stored at controlled room temperature, unless the compounder has formulation-specific stability data [10]. Most compounded vardenafil suspensions carry a 90-day beyond-use date refrigerated (2°C to 8°C) or 30 days at room temperature.
The pH of a compounded vardenafil solution matters. As noted above, the sulfonamide bond is susceptible to hydrolysis below pH 2. Ora-Sweet and Ora-Plus, common compounding vehicles, maintain pH between 4.0 and 4.5, which falls within the stable range. A compounder using a citric acid-based vehicle should verify the final pH does not drop below 3.5.
Patients receiving compounded vardenafil should store it in an amber glass bottle, refrigerated, with the cap tightly sealed. The bottle should never be pre-poured into dosing cups and left at room temperature.
Signs of Degraded Vardenafil: What Patients Can (and Cannot) Detect
Film-coated vardenafil tablets offer limited visual cues for degradation. Color changes (fading of the orange film coat) may indicate photolysis, but a tablet can lose 10% to 15% of its active ingredient without any visible change [5]. Crumbling, chipping, or a strong chemical odor are late-stage signs.
Staxyn ODT provides slightly better sensory feedback. A properly stored Staxyn tablet dissolves cleanly on the tongue with a mild peppermint flavor. If the tablet tastes notably bitter (aspartame degradation) or fails to disintegrate within 10 to 15 seconds, it may have been moisture- or heat-compromised.
The reliable approach: check the expiration date, confirm storage conditions were maintained, and discard any medication that has been exposed to temperature extremes or visible moisture damage. Pharmacists can perform a visual inspection, but quantitative potency testing requires HPLC analysis, which is not available at the point of care. When in doubt, replace the supply.
Disposal of Expired or Unwanted Vardenafil
The FDA recommends returning expired PDE5 inhibitors to a DEA-authorized drug take-back program or an authorized pharmacy collection site [11]. If no take-back option is available, the FDA's household disposal guidance advises mixing tablets with coffee grounds or cat litter in a sealed container before placing in household trash.
Vardenafil should not be flushed. It is not on the FDA's "flush list" of medications that pose acute ingestion risks to children or pets [11]. Flushing PDE5 inhibitors introduces pharmaceutical compounds into municipal water systems, where they have been detected at trace levels in environmental studies [12].
Frequently asked questions
›How long does vardenafil last after the expiration date?
›Can I store Levitra in the refrigerator?
›Does vardenafil go bad in heat?
›How should I store Staxyn ODT tablets?
›Is it safe to put vardenafil in a weekly pill organizer?
›What does vardenafil look like when it goes bad?
›How does vardenafil work as a PDE5 inhibitor?
›What is the difference between Levitra and Staxyn storage requirements?
›Can I travel with vardenafil on an airplane?
›Does light damage vardenafil?
›How do I dispose of expired vardenafil?
›Is generic vardenafil stored the same way as brand-name Levitra?
References
- Bayer HealthCare. Levitra (vardenafil hydrochloride) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s014lbl.pdf
- Bayer HealthCare. Staxyn (vardenafil hydrochloride) orally disintegrating tablets prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022206lbl.pdf
- International Council for Harmonisation. ICH Q1A(R2): Stability testing of new drug substances and products. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q1ar2-stability-testing-new-drug-substances-and-products
- Lyon RC, Taylor JS, Porter DA, et al. Stability profiles of drug products extended beyond labeled expiration dates. J Pharm Sci. 2006;95(7):1549-1560. https://pubmed.ncbi.nlm.nih.gov/16721793/
- Aboul-Enein HY, Ali I. Validated stability-indicating methods for the determination of vardenafil. J Pharm Biomed Anal. 2006;40(4):1068-1073. https://pubmed.ncbi.nlm.nih.gov/16242280/
- Eli Lilly. Cialis (tadalafil) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf
- Vivus Inc. Stendra (avanafil) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202276s000lbl.pdf
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- United States Pharmacopeia. USP General Chapter 795: Pharmaceutical compounding, nonsterile preparations. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- U.S. Food and Drug Administration. Where and how to dispose of unused medicines. https://www.fda.gov/consumers/consumer-updates/where-and-how-dispose-unused-medicines
- U.S. National Library of Medicine. Pharmaceutical contaminants in water systems. https://pubmed.ncbi.nlm.nih.gov/